Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Avingtrans subsidiary gets CE marking for orthopaedic imaging system

Tue, 12th May 2026 13:49

(Sharecast News) - Avingtrans said on Tuesday that its Adaptix subsidiary had received CE certification for the Adaptix Ortho350, its orthopaedic 3D imaging system, allowing the technology to be commercialised across UK and European healthcare markets.

The AIM-traded engineering group said the certification demonstrated that the Ortho350 met EU and UK safety, health and environmental protection requirements.

Adaptix, based at the Oxford University Science Park, develops low-dose 3D digital tomosynthesis imaging systems designed for point-of-care use.

It described the Ortho350 as a compact, mobile system developed for imaging upper and lower extremities, including hands, elbows, shoulders, knees and feet.

Avingtrans said it could provide high-resolution 3D X-ray imaging at a fraction of the radiation dose of traditional CT systems and at a lower cost, while giving clinicians clearer images than 2D X-ray systems, faster patient workflows and improved diagnostic confidence.

Adaptix already supplies its 3D imaging technology to veterinary and industrial non-destructive testing markets through its VetSA3D and NDT3D product lines.

Avingtrans said CE certification marked a major inflection point by opening the human imaging market in the UK and Europe, supporting potential revenue growth and commercial partnerships.

"Receiving our CE certificate for the Adaptix Ortho350 is a defining moment for the company in our mission to transform radiology," said Stuart Gall, chief executive of Avingtrans's medical and industrial imaging division.

"This approval enables us to bring truly disruptive, low dose 3D imaging directly to clinicians and patients in the UK and Europe.

"For our shareholders, this milestone unlocks significant commercial opportunities and accelerates our pathway toward scaled adoption in human healthcare."

At 1326 BST, shares in Avingtrans were up 2.42% at 655.49p.

Reporting by Josh White for Sharecast.com.

See latest RNS on Investegate

Market News Avingtrans

Shares in this article

Related News

Euro zone bond yields muted, with cooling inflation and Iran talks in focus
45 mins ago

Euro zone bond yields muted, with cooling inflation and Iran talks in focus

LONDON, July ​1 (Reuters) - Euro ⁠zone bond yields rose slightly on Wednesday ​after Iran said it would not meet U.S. delegates for talks in Qatar, ca...

Oriole confirms further gold mineralisation at Mbe deposit
1 hour ago

Oriole confirms further gold mineralisation at Mbe deposit

(Sharecast News) - Oriole Resources said on Wednesday that step-out drilling had confirmed further gold mineralisation at the MB01-S deposit at its 50...

Seeing Machines on track to refinance convertible note
1 hour ago

Seeing Machines on track to refinance convertible note

(Sharecast News) - Seeing Machines said on Wednesday that it remained on track to refinance its convertible note well before its 4 October 2026 maturi...